o2h ChaiTime London - Biotech Breakfast Club 2026
Join us for another edition of o2h ChaiTime: Biotech Breakfast Club in London, taking place on Wednesday, 4 November 2026, from 08:30–12:00.
This edition aims to bring together leaders from across biotech, pharma, academia and investment for a morning focused on what’s really happening in biotech, what is changing, and where the sector is heading next.
Draft Agenda
8:30–9:30 | Registration, refreshments and networking
9:30–9:45 | Welcome remarks
9:45–10:05 | Keynote: Biotech Market Outlook by J.P. Morgan
10:05–10:40 | Panel I: Structuring Global Success from Discovery to Clinic
Moderator: Sunil Shah, CEO - o2h Ventures
Panellists:
Sam Fazeli, Director of Research, Global Industries - Bloomberg Intelligence
Dr Miles Congreve, Chief Scientific Officer - Isomorphic Labs
Clare Terlouw, Managing Partner - LifeArc Ventures
Tim Haines, Executive Partner & Managing Director - Abingworth
10:40–11:00 | Coffee break and networking
11:00–11:35 | Panel II: The Evolving Oncology Landscape: Is the Investment Thesis Still Intact?
Moderator: Dr Tim Sparey, Executive Chair - Tay Tx
Panellists:
Richard Ward, Executive Director, Oncology Search & Evaluation - GSK
Tony Hickson, Chief Business Officer - Cancer Research Horizons
Tiffany Thorn, CEO & Founder, BiVictriX Therapeutics
Dr Ramsay McFarlane, CEO & Co-Founder, Awen Oncology
11:35–11:45 | Closing remarks
The morning will also provide plenty of time to exchange views, meet peers and continue the conversation over refreshments and networking.
Important Note
Please register your interest by joining the waitlist via this link. Joining the waitlist is an expression of interest only and does not confirm attendance. As this is an invite-only gathering, all registrations will be reviewed as part of the invitation process, and the J.P. Morgan Events team will issue the final official invitations to confirmed attendees.
If you have any queries, please contact us at invest@o2h.com.